AstraZeneca and Merck Establish Strategic Oncology Collaboration
Go back to AstraZeneca and Merck Establish Strategic Oncology Collaboration| Merck & Co. (NYSE: MRK) | Delayed: 125.60 +5.00 (4.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.60 | 52 Week High | $65.46 | |||
| Open | $121.63 | 52 Week Low | $47.97 | |||
| Day High | $125.96 | P/E | 85.44 | |||
| Day Low | $121.00 | EPS | $1.47 | |||
| Volume | 9,259,182 | |||||

